These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23298521)

  • 1. Stem cells and the treatment of Parkinson's disease.
    Ali F; Stott SR; Barker RA
    Exp Neurol; 2014 Oct; 260():3-11. PubMed ID: 23298521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
    Playne R; Connor B
    Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in direct reprogramming of dopaminergic cell replacement therapy.
    Zheng YY; Xu H; Wang YS
    Neurol Sci; 2024 Mar; 45(3):873-881. PubMed ID: 37945931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards stem cell based therapies for Parkinson's disease.
    Parmar M
    Development; 2018 Jan; 145(1):. PubMed ID: 29311261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Therapy for Parkinson's Disease.
    Yasuhara T; Kameda M; Sasaki T; Tajiri N; Date I
    Cell Transplant; 2017 Sep; 26(9):1551-1559. PubMed ID: 29113472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.
    Nishimura K; Takahashi J
    Biol Pharm Bull; 2013; 36(2):171-5. PubMed ID: 23370347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cells for Modeling and Therapy of Parkinson's Disease.
    Zhang Q; Chen W; Tan S; Lin T
    Hum Gene Ther; 2017 Jan; 28(1):85-98. PubMed ID: 27762639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats.
    Zhang N; Lu X; Wu S; Li X; Duan J; Chen C; Wang W; Song H; Tong J; Li S; Liu Y; Kang X; Wang X; Han F
    Cytotherapy; 2018 May; 20(5):670-686. PubMed ID: 29576501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From stem cells to dopamine neurons: developmental biology meets neurodegeneration.
    Tailor J; Andreska T; Kittappa R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):893-6. PubMed ID: 23131155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
    Kirkeby A; Parmar M; Barker RA
    Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
    Zhao J; Xu Q
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells in the treatment of Parkinson's disease.
    Arenas E
    Brain Res Bull; 2002 Apr; 57(6):795-808. PubMed ID: 12031276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.
    Takahashi H; Ishikawa H; Tanaka A
    Hum Cell; 2017 Apr; 30(2):60-71. PubMed ID: 28210976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the clinical advancement of cell therapies for Parkinson's disease.
    Skidmore S; Barker RA
    Nat Biomed Eng; 2023 Apr; 7(4):370-386. PubMed ID: 36635420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
    Grow DA; McCarrey JR; Navara CS
    Stem Cell Res; 2016 Sep; 17(2):352-366. PubMed ID: 27622596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy for Parkinson's disease is coming of age: current challenges and future prospects with a focus on immunomodulation.
    Wenker SD; Pitossi FJ
    Gene Ther; 2020 Feb; 27(1-2):6-14. PubMed ID: 30992523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing stem cell therapies for Parkinson's disease: waiting until the time is right.
    Barker RA
    Cell Stem Cell; 2014 Nov; 15(5):539-42. PubMed ID: 25517462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.